{
    "title": "WFS1 Gene-associated Diabetes Phenotypes and Identification of a Founder Mutation in Southern India.",
    "doc_id": "35018440",
    "writer": "Chapla A",
    "year": "2022",
    "summary": "CONTEXT: Wolfram syndrome (WFS) is a rare autosomal recessive disorder characterized by juvenile-onset diabetes, diabetes insipidus, optic atrophy, deafness, and progressive neurodegeneration. However, due to the progressive nature of the disease and a lack o â€¦",
    "abstract": "Context:\n        \n      \n      Wolfram syndrome (WFS) is a rare autosomal recessive disorder characterized by juvenile-onset diabetes, diabetes insipidus, optic atrophy, deafness, and progressive neurodegeneration. However, due to the progressive nature of the disease and a lack of complete clinical manifestations, a confirmed diagnosis of WFS at the time of onset of diabetes is a challenge.\n    \n\n\n          Objective:\n        \n      \n      With WFS1 rare heterozygous variants reported in diabetes, there is a need for comprehensive genetic screening strategies for the early diagnosis of WFS and delineating the phenotypic spectrum associated with the WFS1 gene variants in young-onset diabetes.\n    \n\n\n          Methods:\n        \n      \n      This case series of 11 patients who were positive for WFS1 variants were identified with next-generation sequencing (NGS)-based screening of 17 genemonogenic diabetes panel. These results were further confirmed with Sanger sequencing.\n    \n\n\n          Results:\n        \n      \n      9 out of 11 patients were homozygous for pathogenic/likely pathogenic variants in the WFS1 gene. Interestingly, 3 of these probands were positive for the novel WFS1 (NM_006005.3): c.1107_1108insA (p.Ala370Serfs*173) variant, and haplotype analysis suggested a founder effect in 3 families from Southern India. Additionally, we identified 2 patients with young-onset diabetes who were heterozygous for a likely pathogenic variant or a variant of uncertain significance in the WFS1 gene.\n    \n\n\n          Conclusion:\n        \n      \n      These results project the need for NGS-based parallel multigene testing as a tool for early diagnosis of WFS and identify heterozygous WFS1 variants implicated in young-onset diabetes.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/35018440/",
    "clean_text": "wfs gene associated diabetes phenotypes and identification of a founder mutation in southern india context wolfram syndrome wfs is a rare autosomal recessive disorder characterized by juvenile onset diabetes diabetes insipidus optic atrophy deafness and progressive neurodegeneration however due to the progressive nature of the disease and a lack o context wolfram syndrome wfs is a rare autosomal recessive disorder characterized by juvenile onset diabetes diabetes insipidus optic atrophy deafness and progressive neurodegeneration however due to the progressive nature of the disease and a lack of complete clinical manifestations a confirmed diagnosis of wfs at the time of onset of diabetes is a challenge objective with wfs rare heterozygous variants reported in diabetes there is a need for comprehensive genetic screening strategies for the early diagnosis of wfs and delineating the phenotypic spectrum associated with the wfs gene variants in young onset diabetes methods this case series of patients who were positive for wfs variants were identified with next generation sequencing ngs based screening of genemonogenic diabetes panel these results were further confirmed with sanger sequencing results out of patients were homozygous for pathogenic likely pathogenic variants in the wfs gene interestingly of these probands were positive for the novel wfs nm c insa p ala serfs variant and haplotype analysis suggested a founder effect in families from southern india additionally we identified patients with young onset diabetes who were heterozygous for a likely pathogenic variant or a variant of uncertain significance in the wfs gene conclusion these results project the need for ngs based parallel multigene testing as a tool for early diagnosis of wfs and identify heterozygous wfs variants implicated in young onset diabetes"
}